Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 11, 2023
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study
Qinglu Cheng, Heather Valerio, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
March 2, 2023
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study
Jason Grebely, Rosie Gilliver, Tony McNaughton, et al.
Drug and Alcohol Review
|
April 20, 2022
The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions
Lauren A Monds, Maria Bravo, Llewellyn Mills, et al.
Open Forum Infectious Diseases
|
November 29, 2023
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study
Anna Conway, Annabelle Stevens, Carolyn Murray, et al.
Epidemiology and Infection
|
July 30, 2025
Hepatitis B susceptibility and subsequent vaccination in priority populations across an Australian sentinel surveillance network, 2017<i>-</i>2023
Leila Bell, Virginia Pilcher, Elly Layton, et al.
Journal of Viral Hepatitis
|
April 14, 2019
Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study
Sahar Bajis, Jason Grebely, Lucy Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 25, 2020
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis
Jason Grebely, Lucy Tran, Louisa Degenhardt, et al.
Hepatology Communications
|
November 3, 2021
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study
Jasmine Yee, Joanne M Carson, Behzad Hajarizadeh, et al.
Journal of Viral Hepatitis
|
May 18, 2022
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort
Joanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
The International Journal on Drug Policy
|
April 12, 2024
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study
Heather Valerio, Alison D Marshall, Anna Conway, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 11, 2023
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study
Qinglu Cheng, Heather Valerio, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
March 2, 2023
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study
Jason Grebely, Rosie Gilliver, Tony McNaughton, et al.
Drug and Alcohol Review
|
April 20, 2022
The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions
Lauren A Monds, Maria Bravo, Llewellyn Mills, et al.
Open Forum Infectious Diseases
|
November 29, 2023
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study
Anna Conway, Annabelle Stevens, Carolyn Murray, et al.
Epidemiology and Infection
|
July 30, 2025
Hepatitis B susceptibility and subsequent vaccination in priority populations across an Australian sentinel surveillance network, 2017<i>-</i>2023
Leila Bell, Virginia Pilcher, Elly Layton, et al.
Journal of Viral Hepatitis
|
April 14, 2019
Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study
Sahar Bajis, Jason Grebely, Lucy Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 25, 2020
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis
Jason Grebely, Lucy Tran, Louisa Degenhardt, et al.
Hepatology Communications
|
November 3, 2021
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study
Jasmine Yee, Joanne M Carson, Behzad Hajarizadeh, et al.
Journal of Viral Hepatitis
|
May 18, 2022
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort
Joanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
The International Journal on Drug Policy
|
April 12, 2024
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study
Heather Valerio, Alison D Marshall, Anna Conway, et al.
Page
of 9